FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2802456809> ?p ?o ?g. }

• W2802456809 endingPage "e020741" @default.
• W2802456809 startingPage "e020741" @default.
• W2802456809 abstract "<h3>Introduction</h3> Coagulopathic bleeding is a serious complication of cardiac surgery to which an important contributor is acquired hypofibrinogenaemia (plasma fibrinogen <1.5–2.0 g/L). The standard intervention for acquired hypofibrinogenaemia is cryoprecipitate, but purified fibrinogen concentrates are also available. There is little comparative data between the two therapies and randomised trials are needed. <h3>Methods and analysis</h3> FIBrinogen REplenishment in Surgery (FIBRES) is a multicentre, randomised (1:1), active-control, single-blinded, phase III trial in adult cardiac surgical patients experiencing clinically significant bleeding related to acquired hypofibrinogenaemia. The primary objective is to demonstrate that fibrinogen concentrate (Octafibrin/Fibryga; Octapharma) is non-inferior to cryoprecipitate. All patients for whom fibrinogen supplementation is ordered by the clinical team within 24 hours of cardiopulmonary bypass will receive 4 g of fibrinogen concentrate or 10 units of cryoprecipitate (dose-equivalent to 4 g), based on random allocation and deferred consent. The primary outcome is total red cell, platelet and plasma transfusions administered within 24 hours of bypass. Secondary outcomes include major bleeding, fibrinogen levels and adverse events within 28 days. Enrolment of 1200 patients will provide >90% power to demonstrate non-inferiority. One preplanned interim analysis will include 600 patients. The pragmatic design and treatment algorithm align with standard practice, aiding adherence and generalisability. <h3>Ethics and dissemination</h3> The study is approved by the local research ethics board and will be conducted in accordance with the Declaration of Helsinki, Good Clinical Practice guidelines and regulatory requirements. Patient consent prior to treatment is waived, as per criteria in the Tri-Council Policy Statement. Results will be published in the scientific/medical literature, and at international congresses. Non-inferiority of purified fibrinogen concentrate would support its use in acquired hypofibrinogenaemia. The results are likely to improve care for cardiac surgical patients experiencing significant bleeding, an understudied yet high-risk population. <h3>Trial registration number</h3> NCT03037424; Pre-results." @default.
• W2802456809 created "2018-05-17" @default.
• W2802456809 creator A5003839957 @default.
• W2802456809 creator A5015950115 @default.
• W2802456809 creator A5042159661 @default.
• W2802456809 creator A5043621364 @default.
• W2802456809 creator A5079941141 @default.
• W2802456809 creator A5085988392 @default.
• W2802456809 creator A5090011318 @default.
• W2802456809 date "2018-04-01" @default.
• W2802456809 modified "2023-10-18" @default.
• W2802456809 title "Protocol for a phase III, non-inferiority, randomised comparison of a new fibrinogen concentrate versus cryoprecipitate for treating acquired hypofibrinogenaemia in bleeding cardiac surgical patients: the FIBRES trial" @default.
• W2802456809 cites W1192911807 @default.
• W2802456809 cites W1483837246 @default.
• W2802456809 cites W1523698303 @default.
• W2802456809 cites W1765452905 @default.
• W2802456809 cites W1835760130 @default.
• W2802456809 cites W1964496447 @default.
• W2802456809 cites W1972004375 @default.
• W2802456809 cites W2003993899 @default.
• W2802456809 cites W2010881564 @default.
• W2802456809 cites W2013204694 @default.
• W2802456809 cites W2052847754 @default.
• W2802456809 cites W2053986303 @default.
• W2802456809 cites W2057049794 @default.
• W2802456809 cites W2061786051 @default.
• W2802456809 cites W2068086215 @default.
• W2802456809 cites W2075501699 @default.
• W2802456809 cites W2080712219 @default.
• W2802456809 cites W2087373046 @default.
• W2802456809 cites W2123086946 @default.
• W2802456809 cites W2125665418 @default.
• W2802456809 cites W2130891777 @default.
• W2802456809 cites W2131165482 @default.
• W2802456809 cites W2153996899 @default.
• W2802456809 cites W2521157042 @default.
• W2802456809 cites W2613891180 @default.
• W2802456809 cites W29311527 @default.
• W2802456809 cites W4211014988 @default.
• W2802456809 doi "https://doi.org/10.1136/bmjopen-2017-020741" @default.
• W2802456809 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5914770" @default.
• W2802456809 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29678987" @default.
• W2802456809 hasPublicationYear "2018" @default.
• W2802456809 type Work @default.
• W2802456809 sameAs 2802456809 @default.
• W2802456809 citedByCount "15" @default.
• W2802456809 countsByYear W28024568092018 @default.
• W2802456809 countsByYear W28024568092019 @default.
• W2802456809 countsByYear W28024568092020 @default.
• W2802456809 countsByYear W28024568092021 @default.
• W2802456809 countsByYear W28024568092022 @default.
• W2802456809 countsByYear W28024568092023 @default.
• W2802456809 crossrefType "journal-article" @default.
• W2802456809 hasAuthorship W2802456809A5003839957 @default.
• W2802456809 hasAuthorship W2802456809A5015950115 @default.
• W2802456809 hasAuthorship W2802456809A5042159661 @default.
• W2802456809 hasAuthorship W2802456809A5043621364 @default.
• W2802456809 hasAuthorship W2802456809A5079941141 @default.
• W2802456809 hasAuthorship W2802456809A5085988392 @default.
• W2802456809 hasAuthorship W2802456809A5090011318 @default.
• W2802456809 hasBestOaLocation W28024568091 @default.
• W2802456809 hasConcept C126322002 @default.
• W2802456809 hasConcept C141071460 @default.
• W2802456809 hasConcept C168563851 @default.
• W2802456809 hasConcept C177713679 @default.
• W2802456809 hasConcept C2778258694 @default.
• W2802456809 hasConcept C2778789114 @default.
• W2802456809 hasConcept C2779036427 @default.
• W2802456809 hasConcept C2779936836 @default.
• W2802456809 hasConcept C535046627 @default.
• W2802456809 hasConcept C71924100 @default.
• W2802456809 hasConceptScore W2802456809C126322002 @default.
• W2802456809 hasConceptScore W2802456809C141071460 @default.
• W2802456809 hasConceptScore W2802456809C168563851 @default.
• W2802456809 hasConceptScore W2802456809C177713679 @default.
• W2802456809 hasConceptScore W2802456809C2778258694 @default.
• W2802456809 hasConceptScore W2802456809C2778789114 @default.
• W2802456809 hasConceptScore W2802456809C2779036427 @default.
• W2802456809 hasConceptScore W2802456809C2779936836 @default.
• W2802456809 hasConceptScore W2802456809C535046627 @default.
• W2802456809 hasConceptScore W2802456809C71924100 @default.
• W2802456809 hasIssue "4" @default.
• W2802456809 hasLocation W28024568091 @default.
• W2802456809 hasLocation W28024568092 @default.
• W2802456809 hasLocation W28024568093 @default.
• W2802456809 hasLocation W28024568094 @default.
• W2802456809 hasOpenAccess W2802456809 @default.
• W2802456809 hasPrimaryLocation W28024568091 @default.
• W2802456809 hasRelatedWork W1837030616 @default.
• W2802456809 hasRelatedWork W1995407308 @default.
• W2802456809 hasRelatedWork W2124947475 @default.
• W2802456809 hasRelatedWork W2416369082 @default.
• W2802456809 hasRelatedWork W2944702111 @default.
• W2802456809 hasRelatedWork W3132482680 @default.
• W2802456809 hasRelatedWork W3156233647 @default.
• W2802456809 hasRelatedWork W4283660947 @default.
• W2802456809 hasRelatedWork W4285185766 @default.
• W2802456809 hasRelatedWork W4311450203 @default.

• next